These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31667813)

  • 1. Glycogen in Astrocytes and Neurons: Physiological and Pathological Aspects.
    Duran J; Gruart A; López-Ramos JC; Delgado-García JM; Guinovart JJ
    Adv Neurobiol; 2019; 23():311-329. PubMed ID: 31667813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.
    Augé E; Pelegrí C; Manich G; Cabezón I; Guinovart JJ; Duran J; Vilaplana J
    Glia; 2018 Oct; 66(10):2094-2107. PubMed ID: 30152044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease.
    Duran J; Hervera A; Markussen KH; Varea O; López-Soldado I; Sun RC; Del Río JA; Gentry MS; Guinovart JJ
    Brain; 2021 Sep; 144(8):2349-2360. PubMed ID: 33822008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders.
    Duran J
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain glycogen in health and disease.
    Duran J; Guinovart JJ
    Mol Aspects Med; 2015 Dec; 46():70-7. PubMed ID: 26344371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.
    Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P
    Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.
    Varea O; Duran J; Aguilera M; Prats N; Guinovart JJ
    Neurobiol Dis; 2021 Jan; 147():105173. PubMed ID: 33171226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal glycogen synthesis contributes to physiological aging.
    Sinadinos C; Valles-Ortega J; Boulan L; Solsona E; Tevy MF; Marquez M; Duran J; Lopez-Iglesias C; Calbó J; Blasco E; Pumarola M; Milán M; Guinovart JJ
    Aging Cell; 2014 Oct; 13(5):935-45. PubMed ID: 25059425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease.
    Valles-Ortega J; Duran J; Garcia-Rocha M; Bosch C; Saez I; Pujadas L; Serafin A; Cañas X; Soriano E; Delgado-García JM; Gruart A; Guinovart JJ
    EMBO Mol Med; 2011 Nov; 3(11):667-81. PubMed ID: 21882344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion.
    Chambers JK; Thongtharb A; Shiga T; Azakami D; Saito M; Sato M; Morozumi M; Nakayama H; Uchida K
    Vet Pathol; 2018 Jul; 55(4):543-551. PubMed ID: 29444631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease.
    Israelian L; Nitschke S; Wang P; Zhao X; Perri AM; Lee JPY; Verhalen B; Nitschke F; Minassian BA
    J Neurochem; 2021 Jun; 157(6):1897-1910. PubMed ID: 32892347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
    Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
    J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen hyperphosphorylation underlies lafora body formation.
    Turnbull J; Wang P; Girard JM; Ruggieri A; Wang TJ; Draginov AG; Kameka AP; Pencea N; Zhao X; Ackerley CA; Minassian BA
    Ann Neurol; 2010 Dec; 68(6):925-33. PubMed ID: 21077101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting glycogen synthesis prevents Lafora disease in a mouse model.
    Pederson BA; Turnbull J; Epp JR; Weaver SA; Zhao X; Pencea N; Roach PJ; Frankland PW; Ackerley CA; Minassian BA
    Ann Neurol; 2013 Aug; 74(2):297-300. PubMed ID: 23913475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglucosan body structure in Lafora disease.
    Brewer MK; Putaux JL; Rondon A; Uittenbogaard A; Sullivan MA; Gentry MS
    Carbohydr Polym; 2020 Jul; 240():116260. PubMed ID: 32475552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.
    Moreno-Estellés M; Campos-Rodríguez Á; Rubio-Villena C; Kumarasinghe L; Garcia-Gimeno MA; Sanz P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.
    Machado-Salas J; Avila-Costa MR; Guevara P; Guevara J; Durón RM; Bai D; Tanaka M; Yamakawa K; Delgado-Escueta AV
    Exp Neurol; 2012 Jul; 236(1):131-40. PubMed ID: 22542948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora.
    Pellegrini P; Hervera A; Varea O; Brewer MK; López-Soldado I; Guitart A; Aguilera M; Prats N; Del Río JA; Guinovart JJ; Duran J
    Mol Neurobiol; 2022 Feb; 59(2):1214-1229. PubMed ID: 34962634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
    Gumusgoz E; Kasiri S; Guisso DR; Wu J; Dear M; Verhalen B; Minassian BA
    Neurotherapeutics; 2022 Apr; 19(3):982-993. PubMed ID: 35347645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.